“Combined with Agilent’s latest in chromatography (Agilent 1290 INFINITY- II series UHPLC), this system allows our QUAL team to achieve their structure elucidation goals in much faster time due to the speed of separation by UHPLC and the inherent stability of the masses witnessed in the X500B,” emphasizes Dan Safarpour, CEO of Symbiotic Research.
The X500B equipped with two turbo pumps is designed to handle large molecules in addition to small. This is advantageous to the SRL metabolite ID team since some metabolic pathways involve small molecules going through biosynthesis and getting entangled with production of physiologically relevant large proteins and peptides (please attend our presentation in ACS National to be held in September 2021). In addition, the X500 Series can do quantification using High Resolution MRM (HR-MRM) mode.
SRL QUAN team has developed a multi residue method using this system across 28 molecules in commercial samples which will be also presented by its QUAN team at the upcoming National ACS meeting in September 2021.
About Symbiotic Research
SRL (a Tentamus company) is a full GLP, C-14 licensed, life sciences contract research organization which provides in-life and analytical research services to its global clients. SRL is located at 350 Clark Drive, Mount Olive, NJ 07828.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 80 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
CEO Symbiotic Research
Telefon: +1 (908) 887 4345
E-Mail: dan.safarpour@symbioticresearch.net
